SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020
复制标题
DOI：
10.2807/1560-7917.es.2020.25.28.2001285
复制
发表时间：
2020-07-16
期刊：
影响因子：
19
通讯作者：
Vollmer, Tanja
中科院分区：
文献类型：
--
作者：
Fischer, Bastian;Knabbe, Cornelius;Vollmer, Tanja
2019年冠状病毒病的大多数病例是轻度或无症状的。因此，许多案件仍未记录在案。我们测定了2020年3月9日至6月3日期间德国联邦三个州3,186名定期献血者的严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）IgG抗体血清阳性率。IgG血清阳性率总体为0.91%（95%置信区间（CI）：0.58-1.24），范围从黑森的0.66%（95% CI：0.13-1.19）至下萨克森的1.22%（95% CI：0.33-2.10）。
Most cases of coronavirus disease 2019 are mild or asymptomatic. Therefore, many cases remain unrecorded. We determined seroprevalence of IgG antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 3,186 regular blood donors in three German federal states between 9 March and 3 June 2020. The IgG seroprevalence was 0.91% (95% confidence interval (CI): 0.58-1.24) overall, ranging from 0.66% (95% CI: 0.13-1.19) in Hesse to 1.22% (95% CI: 0.33-2.10) in Lower-Saxony.